https://doi.org/10.4081/acbr.2023.331

Prevalence of undiagnosed hypertension among staff of a tertiary institution in Enugu State, Nigeria

Vol. 4 No. 2 (2023)
Submitted: 22 April 2023
Accepted: 12 June 2023
Published: 11 August 2023
Nigeria, prevalence, undiagnosed hypertension, university staff
Abstract Views: 248
PDF: 112
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Hope Obiageli Nwoga
nwogahope@gmail.com
Department of Community Medicine, Enugu State University Teaching Hospital Parklane, Enugu; Department of Community Medicine, Enugu State University College of Medicine, Enugu, Nigeria.
Miriam Obinwanne Ajuba
Department of Community Medicine, Enugu State University Teaching Hospital Parklane, Enugu; Department of Community Medicine, Enugu State University College of Medicine, Enugu, Nigeria.
Chukwuma Paulinus Igweagu
Department of Community Medicine, Enugu State University Teaching Hospital Parklane, Enugu; Department of Community Medicine, Enugu State University College of Medicine, Enugu, Nigeria.

Hypertension is the most important modifiable risk factor for cardiovascular disease, and a high proportion of hypertension in Nigeria remains undiagnosed. The aim of this study was to determine the prevalence of undiagnosed hypertension among the staff of Enugu State University College of Medicine. About 86% (140 of 163) of the staff of the College of Basic and Clinical Medical Sciences, Enugu State University College of Medicine, Enugu, Nigeria, that met the inclusion criteria participated in the study. The blood pressure, weight, and height of consenting staff members were measured. A systolic blood pressure of 140 mmHg and a diastolic blood pressure of 90 mmHg according to the guidelines from the American Heart Association, were classified as hypertension. The weight and height measurements were used to calculate the Body Mass Index (BMI) of the participants. A structured questionnaire was used to collect data on the socio-demographic characteristics. The prevalence of undiagnosed hypertension was 21.4%. Almost half of the participants were pre-hypertensive (48.6%). On bivariate analysis, no socio-demographic characteristic significantly affected the prevalence of hypertension among the participants, but there was an inverse relationship between educational level and prevalence of undiagnosed hypertension. The study showed that there was a high prevalence of undiagnosed hypertension among the staff of Enugu State University College of Medicine. With the above result, there is an urgent need to create awareness and implement measures for early diagnosis of hypertension.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
World Health Organization. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. 2013. Available from: http:// www.who.int/campaigns/world health day/2013/en/index.html
Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-23. DOI: https://doi.org/10.1016/S0140-6736(05)17741-1
Marshall IJ, Wolfe CD, McKevitt C. Lay perspectives on hypertension and drug adherence: Systematic review of qualitative research. BMJ 2012;345:e3953. DOI: https://doi.org/10.1136/bmj.e3953
Novo S, Lunetta M, Evola S, Novo G. Role of ARBs in the blood hypertension therapy and prevention of cardiovascular events. Curr Drug Targets 2009;10:20-5. DOI: https://doi.org/10.2174/138945009787122897
Opie LH, Seedat YK. Hypertension in Sub Saharan African populations. Circulation 2005;112:3562-8. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.539569
Dickson ME, Sigmund CD. Genetic basis of hypertension: Revisiting angiotensinogen. Hypertension 2006;48:14-20. DOI: https://doi.org/10.1161/01.HYP.0000227932.13687.60
World Health Organization. Global Health Risks. Mortality and Burden of Disease Attributable to Selected Major Risks. 2009. Available from https://apps.who.int/iris/handle/10665/44203
Vasan RS, Beiser A, Seshadri S. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA 2002;287:1003-10. DOI: https://doi.org/10.1001/jama.287.8.1003
Lim SS, Vos T, Flaxman AD. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380: 2224-60. DOI: https://doi.org/10.1016/S0140-6736(12)61766-8
Twagirumukiza M, De Bacquer D, Kips JG, et al. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: An estimate from population studies. J Hypertens 2011;29:1243-52. DOI: https://doi.org/10.1097/HJH.0b013e328346995d
Whelton PK. Epidemiology of hypertension. Lancet 1994;344:101-106. DOI: https://doi.org/10.1016/S0140-6736(94)91285-8
Familoni BO, Ogun SA, Aina AO. Knowledge and awareness of hypertension among patients with systemic hypertension. J Natl Med Assoc 2004;96:620-4.
Ekere AU, Yellowe BE, Umune S. Mortality patterns in the accident and emergency department of an urban hospital in Nigeria. Niger J Clin Pract 2005;8:14-8.
Ogunniyi A, Baiyewu O, Gureje O, et al. Morbidity pattern in a sample of elderly Nigerians resident in Idikan community, Ibadan. West Afr J Med 2001;20:227-31.
Bello M. Nigerians wake up to high blood pressure. Bull World Health Organ 2013;91:242-3. DOI: https://doi.org/10.2471/BLT.13.020413
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52. DOI: https://doi.org/10.1161/01.HYP.0000107251.49515.c2
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. National Institute of Health. Obes Res 1998;6:51S-209S. Erratum in: Obes Res 1998;6:464.
Vincent-Onabajo GO, Adaji JO, Umeonwuka CI. Prevalence of Undiagnosed Hypertension Among Traders at A Regional Market in Nigeria. Ann Med Health Sci Res 2017;7:97-101.
Oladoyinbo CA, Ekerette NN, Ogunubi TI. Obesity and hypertension amongst traders in Ijebu Ode, Nigeria. Afr J Biomed Res 2015;18:23-27.
Bappah BS, Shittu A, Usman JS, et al. Prevalence and correlates of undiagnosed hypertension among staff of a Nigerian university community. Pan Afr Med J 2022;42:80. DOI: https://doi.org/10.11604/pamj.2022.42.80.26464
Ahmed S, Rahman A, Hasan Z, Hasan M. Inequalities in the prevalence of undiagnosed hypertension among Bangladeshi adults: evidence from a nationwide survey. International Journal for Equity in Health 2019;18:33. DOI: https://doi.org/10.1186/s12939-019-0930-5
Zoellner J, Thomson JL, Landry AS, et al. Improvements in blood pressure among undiagnosed hypertensive participants in a community-based lifestyle intervention, Mississippi. 2010; Prev Chronic Dis 2014;11:130269. DOI: https://doi.org/10.5888/pcd11.130269
Khanam MA, Lindeboom W, Koehlmoos TL, et al. Hypertension: adherence to treatment in rural Bangladesh - findings from a population-based study. Glob Heal Action 2014;7:25028. DOI: https://doi.org/10.3402/gha.v7.25028

How to Cite

Nwoga, H. O., Ajuba, M. O., & Igweagu, C. P. (2023). Prevalence of undiagnosed hypertension among staff of a tertiary institution in Enugu State, Nigeria. Annals of Clinical and Biomedical Research, 4(2). https://doi.org/10.4081/acbr.2023.331
Copyright (c) 2023 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.